Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

NCT03996369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

354

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Etrasimod
DRUG: Placebo

Sponsor

Arena Pharmaceuticals